MICHX
Price
$11.65
Change
+$0.40 (+3.56%)
Updated
Sep 8 closing price
Net Assets
71.64M
TCELX
Price
$13.63
Change
+$0.14 (+1.04%)
Updated
Sep 8 closing price
Net Assets
60.38M
Interact to see
Advertisement

MICHX vs TCELX

Header iconMICHX vs TCELX Comparison
Open Charts MICHX vs TCELXBanner chart's image
Matthews China Small Companies Instl
Price$11.65
Change+$0.40 (+3.56%)
VolumeN/A
Net Assets71.64M
T. Rowe Price China Evolution Equity
Price$13.63
Change+$0.14 (+1.04%)
VolumeN/A
Net Assets60.38M
MICHX vs TCELX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MICHX has more cash in the bank: 71.6M vs. TCELX (60.4M). MICHX pays higher dividends than TCELX: MICHX (1.23) vs TCELX (1.12). MICHX was incepted earlier than TCELX: MICHX (8 years) vs TCELX (6 years). TCELX (2.67) is less costly to investors than MICHX (1.50). TCELX is a more actively managed with annual turnover of: 82.40 vs. MICHX (54.39). TCELX has a lower initial minimum investment than MICHX: TCELX (2500) vs MICHX (100000). MICHX annual gain was more profitable for investors over the last year : 50.20 vs. TCELX (41.25). TCELX return over 5 years is better than : -0.44 vs. MICHX (-36.69).
MICHXTCELXMICHX / TCELX
Total Expense Ratio1.201.4086%
Annual Report Gross Expense Ratio1.502.6756%
Fund Existence8 years6 years-
Gain YTD28.58726.791107%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets71.6M60.4M119%
Annual Yield % from dividends1.231.12110%
Returns for 1 year50.2041.25122%
Returns for 3 years6.5215.2443%
Returns for 5 years-36.69-0.448,271%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI44.850.39
+0.88%
Acadian Asset Management Inc
VACHU11.50N/A
N/A
Voyager Acquisition Corp
OLLI132.36-1.04
-0.78%
Ollie's Bargain Outlet Holdings
MESA1.27-0.02
-1.55%
Mesa Air Group
OPRX18.29-0.53
-2.82%
OptimizeRx Corp